[Some pharmacological properties of flavan polymers isolated from hawthorn (Crataegus oxyacantha)].
D000818:Animals; D000931:Antidotes / Q000494:pharmacology; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D002725:Chloroform / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D000431:Ethanol / Q000037:antagonists & inhibitors; D005419:Flavonoids / Q000302:isolation & purification / Q000494:pharmacology* / Q000633:toxicity; D006321:Heart / Q000187:drug effects*; D007022:Hypotension / Q000139:chemically induced; D066298:In Vitro Techniques; D008297:Male; D000432:Methanol / Q000037:antagonists & inhibitors; D051379:Mice; D010936:Plant Extracts / Q000494:pharmacology; D010944:Plants; D011108:Polymers / Q000302:isolation & purification / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D012119:Respiration / Q000187:drug effects
D000931:Antidotes; D005419:Flavonoids; D010936:Plant Extracts; D011108:Polymers; D000431:Ethanol; D002725:Chloroform; D000432:Methanol
Einige pharmakologische Eigenschaften der aus Weissdorn (Crataegus oxyacantha) isolierten Flavan-Polymeren.